Abstract:Abstract Objective LNK (lymphocyte adaptor protein) is an adapter protein negatively regulating JAK/STAT cell signaling pathway. In this study, we observed the effects of variations in LNK gene on the clinical type of myeloproliferative disorders (MPD). Methods A total of 285 MPD cases were recruited, including essential thrombocythemia (ET) 154 cases, polycythemia vera (PV) 76 cases, idiopathic myelofibrosis (IMF) 19 cases, and chronic myeloid leukemia (CML) 36 cases. Ninety-three healthy individuals were used as normal controls. V617F mutation in JAK2 was searched by allele-specific primers method, RT-PCR was used for the detection of BCR/ABL1 fusion gene, and mutations and variations in exons and their flanking sequences of LNK gene were examined by PCR-sequencing. Count data were analyzed by χ2 or Fisher exact test. Results The genotypes of 4 SNPs (rs3184504, rs111340708, rs78894077and rs7973120) could be identified. Missense mutations of A300V, V402M, and R415H in LNK were found in 8 patients, of whom 3 ET patients had homozygous A300V mutation combined with JAK2V617F mutation. The genotypes and allele types of the 3 SNPs (rs3184504, rs111340708 and rs78894077) correlated to the clinical type of MPD. For rs3184504, the allele frequencies of C/T were 0.5/0.5 in normal controls, 0.117/0.883 in ET, 0.132/0.868 in PV, 0.211/0.789 in IMF, and 0.944/0.056 in CML; T allele (p.262Trp) was significantly higher in ET, IMF and PV (P<0.01), and C allele (p.262Arg) was significantly higher in CML (P<0.01), as compared with the controls. For rs78894077, the allele frequencies of C/T were 0.097/0.903 in normal controls, 0.045/0.955 in ET, 0.086/0.914 in PV, 0.053/0.947 in IMF, and 0.167/0.833 in CML; T allele (p.242Ser) was higher in ET (P<0.05) than in normal controls. For rs111340708 which has 2 alleles of repeated sequences (TGGGG x5/TGGGG x4), the allele frequencies of TGGGG x5/TGGGG x4 were 0.462/0.538 in normal controls, 0.719/0.281 in ET, 0.533/0.467 in PV, 0.789/0.211 in IMF, and 0.639/0.361 in CML; TGGGG x4 allele was significantly lower in ET, IMF and CML than in normal controls (P<0.01). However, the allele frequencies of rs3184504 and rs111340708 were unrelated to the presence of JAK2V617F mutation and BCR/ABL1 fusion gene in MPD patients. Conclusion The polymorphisms of SNPs in LNK gene correlated to the clinical type of MPD. Disclosures: No relevant conflicts of interest to declare.

Study of Single Nucleotide Polymorphism of SOCS Gene in Typical Myeloproliferative Neoplasms

Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL

[Study of hypermethylation of SOCS gene in typical myeloproliferative disease]

Clinical Significance of Cytogenetic and Molecular Genetic Abnormalities in 634 Chinese Patients with Myelodysplastic Syndromes

TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia.

Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm

Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases

[Variation of STAT3 Gene in Myleproliferative Neoplasms and Its Significance].

Comprehensive analysis of suppressor of cytokine signaling 2 protein in the malignant transformation of NSCLC

SOCS1 Methylation in Patients with Newly Diagnosed Acute Myeloid Leukemia.

The Polymorphisms In Lnk Gene Correlated To The Clinical Type Of Myeloproliferative Disorders

Identification of SOCS Family Members with Prognostic Values in Human Ovarian Cancer.

The Polymorphisms In Lnk Gene Correlated To The Clinical Type Of Myeloproliferative Neoplasms

SOCS3 as a potential driver of lung metastasis in colon cancer patients

Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer

Integrated Clinical Genotype-phenotype Characteristics of STAT3-mutated Myeloid Neoplasms

Mutation Profiles of Classic Myeloproliferative Neoplasms Detected by a Customized Next-Generation Sequencing-Based 50-Gene Panel

Matrix Metalloproteinase-2 Polymorphisms and Clinical Outcome of Chinese Patients with Nonsmall Cell Lung Cancer Treated with First-Line, Platinum-Based Chemotherapy

Suppressor of Cytokine Signaling 1 Haploinsufficiency

Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer

Analyzing Differences in Hematological and Immunological Characteristics Related to Common Gene Mutations in Myelodysplastic Syndromes